Kondo T, Takemura G, Kosai K, Ohno T, Takahashi T, Esaki M, Goto K, Maruyama R, Murata I, Minatoguchi S, Fujiwra T, Fujiwara H.
Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
Clin Exp Pharmacol Physiol. 35(11):1288-93. 2008
Esaki M, Takemura G, Kosai K, Takahashi T, Miyata S, Li L, Goto K, Maruyama R, Okada H, Kanamori H, Ogino A, Ushikoshi H, Minatoguchi S, Fujiwara T, Fujiwara H.
Treatment with an adenoviral vector encoding hepatosyte growth factor mitigates established cardiac dysfunction in doxorubicin –induced cardiomyopathy.
Am J Physiol Heart Circ Physiol. 294(2): H1048-1057, 2008
Suzuki K, Mitsui K, Aizawa E, Hasegawa K, Kawase E, Yamagishi T, Shimizu Y, Suemori H, Nakatsuji N, Mitani K.
Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors.
Proc Natl Acad Sci USA.105 13781-6. 2008
Subcategories
業績
論文掲載「Translational Research」川上広高、伊地知暢広、小濵祐行、松田恵理子、三井薫、西川路侑耶、渡邉真希、永野聡、谷口昂、小宮節朗、小戝健一郎
『An optimal promoter regulating cytokine transgene expression is crucial for safe and effective oncolytic virus immunotherapy』がTransl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.に掲載されました。
Transl Res. 2024 Jul 3:S1931-5244(24)00142-7. doi: 10.1016/j.trsl.2024.07.002.
